The examination will be conducted in 13 languages, including English, Hindi, Assamese, Bengali, Gujarati, Kannada, Malayalam, Marathi, Odia, Punjabi, Tamil, Telugu and Urdu. Paper 1 for Bachelor of ...

The National Testing Agency (NTA) will close the registration window for JEE Main 2026 Session 1 today, 27 November 2025. Candidates who have not yet completed the application must do so on the ...

The Navy is walking away from the Constellation-class frigate program to focus on new classes of warships the service can build faster, Secretary of the Navy John Phelan announced Tuesday on social ...

IBM (IBM) and Cisco (CSCO) are collaborating to design a connected network of large-scale, fault-tolerant quantum computers, targeted by early 2030s. The companies said that within five years, the two ...

Water service is fully operational again in Coon Rapids after repairs were made to multiple water main breaks, but the sinkhole can’t be fixed until spring. According to Jennifer Anderson, ...

IBM and Cisco have unveiled plans to jointly advance the development of distributed quantum computing networks. The initiative aims to connect large-scale, fault-tolerant quantum computers, with the ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

IBM and Cisco announced an intention to collaborate on the groundwork for networked distributed quantum computing, to be realized as soon as the early 2030s. By combining IBM's leadership in building ...

Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has reached an initial rampdown phase for bug fixes, with the feature set now frozen. The following 10 features are ...

The JEE Main 2026 session 1 application correction window will open on December 1. Candidates after completing the application process can make required changes to their application form until ...

Contineum Therapeutics (CTNM) shares fell following the results from its mid-stage trial of PIPE-307, a treatment aimed at patients with relapsing-remitting multiple sclerosis. The trial did not ...